跳至主要内容
临床试验/ISRCTN11296911
ISRCTN11296911已完成未知

Comparison of skin suction blister method with or without heat plate in a lipopolysaccharide challenge model in healthy volunteers

Centre for Human Drug Research0 个研究点目标入组 12 人开始时间: 2022年6月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Healthy male and female subjects, 18 to 45 years of age, inclusive. Healthy status is defined by the absence of evidence of any active or chronic disease following a detailed medical and surgical history, a complete physical examination including vital signs, 12-lead ECG, hematology, blood chemistry, coagulation, blood serology and urinalysis
  • 2. Body mass index (BMI) between 18 and 32 kg/m2, inclusive, and with a minimum weight of 50 kg
  • 3. Fitzpatrick skin type I-III (Caucasian)
  • 4. Subjects of childbearing potential must use effective contraception for the duration of the study
  • 5. Able and willing to give written informed consent and to comply with the study restrictions

排除标准

  • 1. Any disease associated with immune system impairment, including auto-immune diseases, HIV and transplantation patients
  • 2. Any (medical) condition that would, in the opinion of the investigator, potentially compromise the safety or compliance of the patient or may preclude the patient’s successful completion of the clinical trial
  • 3. Any vaccination within the last month; COVID-19 vaccination is allowed up until 2 weeks before study day 1
  • 4. Have any current and/or recurrent pathologically, clinical significant skin condition at the treatment area (i.e. atopic dermatitis); including tattoos
  • 5. Hypersensitivity for dermatological marker at screening
  • 6. Requirement of immunosuppressive or immunomodulatory medication within 30 days prior to enrolment or planned to use during the course of the study
  • 7. Use of topical medication (prescription or over-the-counter [OTC]) within 30 days prior to day 1, or less than 5 half-lives (whichever is longer) on lower arms
  • 8. Excessive sun exposure or a tanning booth within 3 weeks of enrolment
  • 9. Participation in an investigational drug or device study within 3 months prior to screening or more than 4 times a year
  • 10. Loss or donation of blood over 500 mL within three months prior to screening. Or the donation of plasma within 14 days prior to screening
  • 11. Volunteers with clinically relevant infections
  • 12. Current nicotine use in excess of 5 cigarettes per day or unable to abstain from smoking during the course of the study (from screening till end of study)
  • 13. History of or current drug or substance abuse considered significant by PI (or medically qualified designee), including a positive urine drug screen
  • 14. Covid-19 infection (with positive test result) within the last 4 weeks

研究者

相似试验